| cohort study of human immunodeficiency virus (hiv) antibody testing among patients receiving long-term dialysis at a university hospital. | in a longitudinal study to determine the seroprevalence of antibody to the human immunodeficiency virus (hiv) and the natural history of a positive enzyme immunoassay (eia) result we followed a cohort of 98 patients receiving long-term dialysis. eight patients (8.2%) in the cohort had a positive eia and a negative western blot test result. the eia-positive results of all patients seroconverted to negative during follow-up. no illness suggestive of hiv infection developed in any of the patients. ... | 1988 | 3061313 |
| reducing blood and body fluid exposures among clinical laboratory workers. meeting the osha standards. | this article examines risks and exposure patterns in clinical laboratories to help identify the most effective methods for implementing the osha standard for protection against bloodborne pathogens, especially hepatitis b virus and the human immunodeficiency virus. using eye-opening figures, tables, and statistics, the authors identify areas where clinical laboratorians can improve their protection and conclude by offering three strategies for reducing blood and body fluid exposures in clinical ... | 1992 | 10122816 |
| secondary syringe exchange among injection drug users. | syringe-exchange programs (seps) have proven to prevent the spread of bloodborne pathogens, primarily human immunodeficiency virus (hiv), among injection drug users (idus). in the united states, only about 7% of idus have access to and use seps. some idus engage in secondary syringe exchange (sse), meaning that one idu (a "provider") obtains syringes at an sep to distribute to other idus ("recipients"). this formative qualitative research was conducted to understand why and how idus engage in ss ... | 2003 | 12791808 |